Vanguard Group Inc. Cuts Stock Position in Acadia Healthcare Company, Inc. $ACHC

Vanguard Group Inc. lowered its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 0.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 8,801,781 shares of the company’s stock after selling 78,676 shares during the period. Vanguard Group Inc. owned approximately 9.55% of Acadia Healthcare worth $266,870,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of ACHC. Madison Avenue Partners LP purchased a new position in shares of Acadia Healthcare in the fourth quarter worth $76,339,000. Sachem Head Capital Management LP purchased a new position in shares of Acadia Healthcare in the fourth quarter worth $52,734,000. Khrom Capital Management LLC purchased a new position in shares of Acadia Healthcare in the fourth quarter worth $49,602,000. Balyasny Asset Management L.P. purchased a new position in shares of Acadia Healthcare in the fourth quarter worth $43,092,000. Finally, Brown Advisory Inc. purchased a new position in shares of Acadia Healthcare in the first quarter worth $25,125,000.

Acadia Healthcare Stock Performance

ACHC opened at $21.13 on Tuesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. The firm has a fifty day moving average price of $21.96 and a 200 day moving average price of $26.64. Acadia Healthcare Company, Inc. has a 1 year low of $17.13 and a 1 year high of $82.40. The stock has a market cap of $1.95 billion, a P/E ratio of 13.99, a P/E/G ratio of 4.10 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The firm had revenue of $869.23 million during the quarter, compared to analysts’ expectations of $839.59 million. During the same period in the previous year, the business posted $0.91 EPS. The business’s revenue was up 9.2% compared to the same quarter last year. Equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have issued reports on ACHC. KeyCorp decreased their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating for the company in a report on Wednesday, May 14th. Cowen reaffirmed a “buy” rating on shares of Acadia Healthcare in a report on Thursday, August 7th. UBS Group decreased their price target on shares of Acadia Healthcare from $45.00 to $31.00 and set a “buy” rating for the company in a report on Thursday, August 7th. Guggenheim dropped their price objective on shares of Acadia Healthcare from $36.00 to $29.00 and set a “buy” rating on the stock in a report on Thursday, August 7th. Finally, Stephens raised shares of Acadia Healthcare to a “hold” rating in a report on Monday, June 2nd. Five research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $40.77.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.